From Reactive to Proactive: Claritas Rx Patient Watchtower™ Adds 377+ Patient Months and Boosts First Fill Conversions by 20% in Rare Disease

A mid-sized pharmaceutical company in the rare disease sector faced significant gaps in patient journey visibility and cross-partner coordination. Fragmented data and inconsistent communication between field reimbursement managers (FRMs), specialty pharmacies, and support hubs prevented proactive engagement—leading to processing delays, missed intervention opportunities, and suboptimal patient outcomes.

• Reactive outreach caused by siloed and delayed data across partners.
• Processing delays stemming from unclear benefit investigation and authorization status.
• Missed opportunities to shorten time-to-therapy and optimize support interventions.

• 20% improvement in first fill conversions: Proactive patient status reviews and automated triggers—such as alerts for patients awaiting benefits investigation or prior authorization over 10 days—enabled teams to reduce delays and start more patients on therapy faster.
• 377+ incremental patient months added through coordinated intervention: Enhanced real-time visibility across 14 FRMs, six specialty pharmacy partners, and one hub empowered multi-disciplinary teams to quickly identify stalled patients and resolve shipment or refill delays.
• 0.6-month average increase in therapy duration: Seamless in-app collaboration and data-driven next-best-action guidance helped extend patient time on therapy across the portfolio.

Through this digital transformation, the company broke down data silos, aligned partner workflows, and delivered measurable gains in both patient access and commercial performance.

Source: Claritas Rx, data on file, 2023. Case study based on a mid-sized pharmaceutical company’s rare disease brand.